| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.07 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |